innerbuddies gut microbiome testing

Gut Microbiome and Adult Atopic Dermatitis: How Your Gut Impacts Eczema Flare-Ups

Adult atopic dermatitis (eczema) isn’t driven by skin factors alone—your gut microbiome can also shape how your immune system behaves. The gut hosts trillions of microbes that help train immune responses, influence inflammation signals, and support the balance between protective tolerance and overreactive immunity. When the microbiome is disrupted, the “tone” of inflammation can shift, making flare-ups more likely or harder to control.

This gut–skin connection helps explain why some adults notice that stress, diet changes, certain medications, or recent infections can coincide with eczema worsening. Gut microbes produce metabolites (like short-chain fatty acids) that strengthen gut barrier function and help regulate immune activity throughout the body. If microbial diversity drops or certain protective species decline, barrier function may weaken and inflammatory pathways—often involving cytokines linked to allergic-type inflammation—can become more active, contributing to itchy, inflamed skin.

The good news: supporting a healthier microbiome may complement standard eczema care. By focusing on microbiome-friendly habits—such as emphasizing fiber-rich foods, fermented options when tolerated, and minimizing common flare contributors—you can encourage beneficial microbial balance. In this guide, you’ll learn evidence-based ways the gut influences adult eczema and practical steps to support calmer, steadier skin through your daily routine.

Take the Gut Microbiome Test for Atopic Dermatitis Get Your Gut Microbiome Test Subscription for Atopic Dermatitis
innerbuddies gut microbiome testing

Adult atopic dermatitis

Adult atopic dermatitis (AD) is a chronic, relapsing inflammatory skin condition characterized by itching, dry, scaly patches, and red inflamed areas. A weakened skin barrier and environmental triggers drive flares, which often follow a cyclical pattern; recent research highlights the gut–skin axis, suggesting that gut microbiome health and diet can influence AD symptoms through immune signaling and tolerance. Practical steps include boosting dietary fiber, maintaining regular meals, identifying personal triggers, and supporting skin barrier care alongside standard treatment.

Mechanisms linking the gut to the skin involve dysbiosis shifting immune responses toward pro-inflammatory pathways (Th2/Th17-like activity) and reducing protective metabolites like short-chain fatty acids (SCFAs) such as butyrate and propionate. Reduced SCFAs, impaired gut barrier integrity, and microbial metabolites can promote systemic inflammation and worsen the itch-scratch cycle, especially during stress, infections, or irritant exposure. While no single food or bacteria causes AD, gut-derived factors help explain variable flare frequency and severity.

InnerBuddies offers gut microbiome testing to personalize AD management by identifying diversity and fermentation-pattern changes, guiding targeted dietary and lifestyle adjustments that support immune regulation and barrier function. The test can also be used to monitor progress over time, helping to time and tailor interventions in conjunction with skin barrier care to reduce flare intensity and improve long-term symptom control.

  • Loss of SCFA-producing gut bacteria (Faecalibacterium prausnitzii; Roseburia spp.; Coprococcus comes; Eubacterium rectale; Anaerostipes spp.; Bifidobacterium spp.; Ruminococcus bromii) reduces butyrate/propionate production, weakening immune tolerance and promoting AD flares.
  • Lower levels of Akkermansia muciniphila and other mucosa-associated microbes compromise gut barrier integrity, facilitating skin inflammation and barrier dysfunction in adult atopic dermatitis.
  • Elevated gut pro-inflammatory taxa (Staphylococcus aureus, Streptococcus spp., Escherichia coli, Enterococcus spp., Clostridium spp. non-Faecalibacterium clusters) shift immune signaling toward inflammation and worsen AD symptoms.
  • Dysbiosis alters microbial metabolites—reduced SCFAs and changed bile acid/tryptophan pathways—skewing immune responses toward Th2/Th17 and promoting skin inflammation.
  • Gut barrier impairment from dysbiosis increases translocation of microbial components and inflammatory mediators, priming skin immune cells and worsening keratinocyte barrier function.
  • Gut–brain/neuroendocrine signaling links stress and itch to microbiome activity, amplifying the itch-scratch cycle and flare susceptibility in AD.
  • Microbiome testing and personalized dietary/metabolic strategies (e.g., targeted fiber intake) can tailor AD management, complementing skin barrier therapies to reduce flare frequency and severity.
Take the Gut Microbiome Test for Atopic Dermatitis Get Your Gut Microbiome Test Subscription for Atopic Dermatitis
innerbuddies gut microbiome testing

Atopic dermatitis / eczema

Adult atopic dermatitis (AD), commonly known as eczema, is a chronic, relapsing inflammatory skin condition driven by a mix of immune dysregulation, skin barrier impairment, and environmental triggers. When the skin barrier is “leaky,” irritants and microbes can penetrate more easily, which activates inflammatory pathways and contributes to itching, redness, and flare-ups. For many adults, symptoms also follow a cyclical pattern—periods of relative control can be disrupted by stress, infections, allergens, weather changes, or dietary factors.

In recent years, research has highlighted the gut–skin axis: the gut microbiome helps shape immune responses that can influence inflammatory conditions like AD. A balanced and diverse microbiome supports the production of beneficial metabolites (such as short-chain fatty acids) that help regulate immune signaling and maintain tolerance. In contrast, dysbiosis—an imbalance in gut bacteria—may promote a more inflammatory immune environment, potentially increasing susceptibility to flares. This connection is thought to involve multiple routes, including microbial metabolites, gut barrier integrity, and systemic immune activation that can “echo” back to the skin.

Understanding your triggers through the lens of the gut–skin connection can make flares more manageable. While no single food or bacteria “causes” AD, patterns such as high ultra-processed food intake, low fiber diets, antibiotic exposure, and certain sensitivities may shift the microbiome and influence inflammation. Practical, evidence-informed steps often include improving fiber intake to support beneficial bacteria, maintaining consistent meal patterns, considering individualized food triggers, and supporting skin barrier care in parallel. Together, these strategies may help create a more resilient inflammatory profile—supporting calmer skin and fewer flare-ups over time.

  • Itching (pruritus) that may worsen with flare-ups
  • Dry, rough, scaly skin
  • Red or inflamed patches of skin (erythema)
  • Thickened or lichenified skin from chronic scratching
  • Rashes that can occur in typical areas (e.g., elbows, knees, hands, neck)
  • Crusting, oozing, or weeping from more severe inflamed lesions
Take the Gut Microbiome Test for Atopic Dermatitis Get Your Gut Microbiome Test Subscription for Atopic Dermatitis
innerbuddies gut microbiome testing

Adult atopic dermatitis

This information is relevant for adults living with atopic dermatitis (eczema) who experience chronic, relapsing flare-ups—periods of relative improvement followed by itch and inflammation that can be triggered by stress, infections, weather, allergens, or other day-to-day factors. It’s especially useful if your symptoms tend to cycle and you’re looking for a deeper, systems-based explanation beyond topical care alone.

It’s also for people who want to understand the gut–skin connection and how gut microbiome changes may influence immune signaling involved in adult AD. If you suspect that your flare pattern correlates with diet quality (e.g., low fiber intake or high intake of ultra-processed foods), antibiotic exposure, inconsistent eating routines, or broader lifestyle changes, this approach may help you think about how gut dysbiosis could contribute to a more inflammatory “readiness” that shows up as skin redness, dryness, and itching.

Finally, it’s relevant if you’re dealing with classic adult AD symptoms such as persistent pruritus, rough scaly skin, red inflamed patches, thickened/lichenified areas from chronic scratching, or more severe lesions that can crust, ooze, or weep. If you want practical, evidence-informed ways to support your skin barrier and inflammation long-term—while also considering individualized food triggers—this guidance is designed for you.

Adult atopic dermatitis (AD), commonly referred to as eczema, affects a substantial share of the population worldwide and is widely considered common, chronic, and relapsing. While estimates vary by region and methodology, epidemiologic studies generally place prevalence at around 5–10% of adults globally, with many cases beginning in childhood and a meaningful minority continuing into adulthood or starting later. Because AD is influenced by immune dysregulation and skin-barrier impairment, symptoms such as itching, redness, and dry, scaly patches can come and go—often improving for periods before flaring again.

Across adult populations, the burden of AD is reflected in the frequency of typical, recognizable symptoms. Adults often experience persistent or recurrent pruritus (itching) along with dry, rough skin and erythematous inflamed areas, especially in common sites such as the elbows, knees, hands, and neck. For some, chronic scratching leads to thickened/lichenified skin, while more severe episodes may involve oozing or crusting/weepy lesions. This cyclical course contributes to ongoing prevalence at the population level: many people are not “always symptomatic,” but they experience recurrent disease activity over time.

Finally, adult AD prevalence is notable for its association with broader inflammatory patterns that can involve the gut–skin axis. Although no single trigger (including a specific food or gut bacterium) explains all cases, research supports that diet quality and microbiome-related factors can influence immune signaling, potentially affecting susceptibility to flares. Population-level findings that link lower fiber intake, higher ultra-processed food intake, and other lifestyle factors with gut dysbiosis help contextualize why AD remains common and why symptom patterns often fluctuate with environmental and immune stressors—even when overall disease drivers differ between individuals.

Take the Gut Microbiome Test for Atopic Dermatitis Get Your Gut Microbiome Test Subscription for Atopic Dermatitis
innerbuddies gut microbiome testing

Gut Microbiome & Adult Atopic Dermatitis (Eczema): How Your Gut Impacts Flare-Ups

Adult atopic dermatitis (AD) is driven by immune dysregulation and a weakened skin barrier, but mounting evidence points to the gut–skin axis as an important contributor to flare susceptibility. When the gut microbiome is diverse and balanced, it produces metabolites (including short-chain fatty acids) that help regulate inflammatory immune signaling and support immune tolerance. In contrast, gut dysbiosis may promote a more pro-inflammatory immune environment, making it easier for skin inflammation to escalate—especially during stress, infections, or environmental trigger exposure.

Several mechanisms may explain how gut changes “echo” back to the skin. Dysbiosis can affect gut barrier integrity and increase systemic exposure to inflammatory signals, while altered microbial metabolites can shift immune pathways involved in allergic and atopic inflammation. Over time, these immune changes can influence the skin’s inflammatory tone, contributing to the itch-scratch cycle and making characteristic symptoms—like redness, scaly dryness, and thickened (lichenified) patches—more likely to flare.

Diet and microbiome-modulating factors can therefore play a role in AD symptom patterns, even though no single food or bacterium is a stand-alone cause. Diets low in fiber or high in ultra-processed foods may reduce beneficial microbial diversity, while antibiotic exposure can disrupt microbial balance and resilience. Supporting a healthy microbiome—commonly via increased dietary fiber, consistent nutrition habits, and individualized trigger awareness—works best alongside core AD skin barrier care, helping the immune system stay more regulated and potentially reducing the frequency and severity of itching, weeping lesions, and other flare-related symptoms.

Take the Gut Microbiome Test for Atopic Dermatitis Get Your Gut Microbiome Test Subscription for Atopic Dermatitis
innerbuddies gut microbiome testing

Gut Microbiome and Adult atopic dermatitis

  • Gut dysbiosis alters immune signaling: Imbalanced microbial communities skew systemic immune responses toward a more pro-inflammatory profile (e.g., enhanced Th2/Th17-like activity), increasing skin inflammation susceptibility and flare frequency.
  • Reduced microbial metabolite production: Loss of fiber-fermenting taxa can lower short-chain fatty acids (SCFAs like butyrate/propionate), which normally promote immune tolerance and regulate inflammatory pathways; diminished SCFAs can loosen the immune “brakes” that protect skin.
  • Compromised gut barrier increases systemic exposure to inflammatory signals: Dysbiosis can weaken intestinal tight junctions, allowing microbial components and inflammatory mediators to cross into circulation, priming skin immune cells and worsening AD lesions.
  • Metabolite–epithelium immune cross-talk: Microbial metabolites (beyond SCFAs, including bile acid derivatives and tryptophan-related metabolites) influence innate and adaptive immune pathways that shape atopic inflammation in the skin.
  • Vagal and neural–endocrine gut–skin communication: Gut dysregulation can affect neuroimmune signaling (stress-response pathways) that alters skin barrier function, itch perception, and inflammatory thresholds—promoting the itch–scratch cycle.
  • Influence on skin barrier function via systemic inflammation: Chronic low-grade inflammatory signaling originating from gut immune dysregulation can impair keratinocyte barrier integrity and worsen dryness, redness, and lichenification tendencies.
  • Antibiotics and diet-related resilience changes: Antibiotic exposure and low-fiber/high–ultra-processed diets can reduce microbial diversity and recovery capacity, making the host more vulnerable to environmental triggers and infections that precipitate flares.

Adult atopic dermatitis is rooted in immune dysregulation and a weakened skin barrier, but the gut–skin axis helps explain why flares can be more frequent or severe. Gut dysbiosis can shift the overall immune “set point” toward a more pro-inflammatory pattern (often described in atopic terms such as Th2/Th17-like activity). When this systemic immune bias is present, skin inflammation becomes easier to trigger and harder to shut down—especially during stress, infections, or environmental exposures.

A key pathway involves microbial metabolites. When the diet lacks fiber or when microbiome diversity is reduced (for example, after antibiotics or from high–ultra-processed eating patterns), fiber-fermenting bacteria decline and short-chain fatty acids (SCFAs) like butyrate and propionate drop. SCFAs normally support immune tolerance and help regulate inflammatory signaling; when they’re reduced, the body has fewer “checks” on inflammation. At the same time, other microbial byproducts (such as bile acid derivatives and tryptophan-related metabolites) can influence epithelial and immune cross-talk, further shaping atopic-type inflammation in the skin.

Gut barrier impairment adds another layer to the gut–skin connection. Dysbiosis can weaken intestinal tight junctions, increasing systemic exposure to microbial components and inflammatory mediators that can prime skin immune cells. This gut-driven, low-grade inflammatory environment can worsen keratinocyte barrier integrity, contributing to hallmark symptoms like redness, scaling dryness, and lichenification. Finally, gut–brain and neural–endocrine communication can modulate stress-response signaling and itch perception, reinforcing the itch–scratch cycle and lowering the threshold for flares—making microbiome-supporting habits most effective when paired with standard skin barrier care.

Take the Gut Microbiome Test for Atopic Dermatitis Get Your Gut Microbiome Test Subscription for Atopic Dermatitis
innerbuddies gut microbiome testing

Microbial patterns summary

In adult atopic dermatitis, gut–microbiome studies commonly point to a less diverse microbial community and a shift in the balance of bacteria involved in fiber fermentation and immune regulation. When beneficial, fiber-utilizing taxa decline (often due to low-fiber intake, high ultra-processed food consumption, or post-antibiotic disruption), the ecosystem produces fewer protective microbial metabolites. This can reduce short-chain fatty acid (SCFA) availability—such as butyrate and propionate—which normally help maintain immune tolerance and keep inflammatory signaling from tipping toward an atopic, pro-inflammatory pattern.

Alongside reduced SCFA output, dysbiosis may also alter microbial byproducts that influence epithelial and immune cross-talk relevant to skin inflammation. Changes in bile acid–related metabolites and tryptophan-derived pathways can affect how immune cells are “set” toward stronger inflammatory responses, making skin barrier dysfunction more likely to amplify flare activity. In effect, gut immune priming can raise systemic inflammatory tone, so that exposures like infections, stress, or environmental irritants more easily translate into worsening redness, itch, and scaling.

A further pattern involves gut barrier integrity and gut–skin signaling. Dysbiosis can impair intestinal tight junctions, increasing translocation of microbial components and inflammatory mediators into systemic circulation, which can then prime skin immune pathways and weaken keratinocyte barrier function. Through gut–brain and neuroendocrine communication, stress-related signaling and itch sensitivity may also become more pronounced, reinforcing the itch–scratch cycle; this helps explain why microbiome-supporting habits (especially those that restore fermentable fiber intake and resilience after disruptions) often work best when paired with consistent adult atopic dermatitis skin barrier care.


Low beneficial taxa

  • Faecalibacterium prausnitzii
  • Roseburia spp.
  • Coprococcus comes
  • Eubacterium rectale
  • Anaerostipes spp.
  • Bifidobacterium spp.
  • Akkermansia muciniphila
  • Ruminococcus bromii


Elevated / overrepresented taxa

  • Staphylococcus aureus
  • Streptococcus spp.
  • Escherichia coli
  • Enterococcus spp.
  • Clostridium spp. (non-Faecalibacterium clusters)


Functional pathways involved

  • Short-chain fatty acid (SCFA) biosynthesis and butyrate/propionate production via fiber fermentation
  • Tryptophan metabolism toward indole/aryl hydrocarbon receptor (AhR) ligands that modulate immune tolerance
  • Bile acid secondary transformation (microbiota–bile acid–FXR/TGR5 signaling) influencing systemic inflammation and gut–skin immune crosstalk
  • Intestinal tight-junction integrity and mucosal barrier function (gut permeability modulation) reducing translocation of inflammatory microbial products
  • Microbial metabolite-driven regulation of T-cell polarization (e.g., promotion of regulatory T cells and restraint of Th2/Th17-skewing)
  • Epithelial-microbe interaction and inflammatory cross-talk (pattern-recognition receptor signaling such as TLR/NLR pathways) affecting skin barrier and flare propensity
  • Microbial dysbiosis-associated endotoxin/LPS and peptidoglycan processing pathways (influencing systemic innate immune activation)


Diversity note

In adults with atopic dermatitis, gut microbiome studies often show reduced overall diversity and a less balanced community structure. A common theme is a shift away from fiber-fermenting, SCFA-producing bacteria that normally help dampen inflammatory signaling. When these beneficial groups decline—whether due to low dietary fiber, high ultra-processed food intake, recurrent infections, or disruption from antibiotics—the gut ecosystem is less able to generate metabolites that support immune tolerance.

This loss of microbial balance can change the chemical “language” between gut and immune system. Lower availability of short-chain fatty acids (such as butyrate and propionate) may weaken regulatory pathways and make inflammatory responses more easily triggered. Dysbiosis can also alter other metabolite classes (including bile acid–related and tryptophan-derived metabolites) that help shape how immune cells are programmed, potentially increasing the likelihood that immune activation in the gut spills over into a more pro-inflammatory, atopic pattern affecting the skin.

In addition, reduced diversity often coincides with impaired gut barrier function, which can increase exposure of the body to microbial products and inflammatory mediators. That systemic immune “priming” can raise the inflammatory tone that flare triggers—like stress, irritants, or infections—can set off. Over time, these gut-linked immune changes can reinforce the skin’s itch–scratch cycle and worsen barrier dysfunction, making characteristic atopic dermatitis symptoms more prone to recurring or escalating.


Take the Gut Microbiome Test for Atopic Dermatitis Get Your Gut Microbiome Test Subscription for Atopic Dermatitis

Why generic solutions fail

  • Issue with generic solutions

    Generic solutions often fail in adult atopic dermatitis because the condition is not driven by a single dietary trigger or one “bad” microbe. Gut–skin interactions depend on each person’s baseline microbiome diversity, stool pattern, fiber tolerance, immune phenotype, stress load, medication history (especially antibiotics), and the current state of skin barrier dysfunction. A one-size-fits-all plan that simply adds supplements or removes a broad category of foods may not rebuild the specific microbial ecosystem needed to generate anti-inflammatory metabolites like short-chain fatty acids (e.g., butyrate/propionate) and may leave key drivers—such as low fermentable fiber intake or ongoing gut barrier stress—unchanged.

    They also tend to overlook timing and momentum. After a disruption (antibiotic use, illness, or a sudden dietary shift), microbiome resilience and metabolic output often take weeks to months to normalize, and gut barrier integrity may lag behind symptomatic improvements. Generic protocols that promise quick symptom relief can miss this lag, leading to premature stopping or cycling through interventions that further destabilize microbial function. Even when people temporarily reduce triggers, the underlying immune “set point” and itch-scratch amplification loop may persist if skin barrier care and immune regulation aren’t addressed consistently alongside gut-focused changes.

    Finally, many generic approaches ignore variability in food responses and gut tolerance. Fermentable fibers that help one person may worsen symptoms or compliance in another, and ultra-restriction can inadvertently reduce microbial diversity. Because atopic dermatitis flares can be influenced by infections, environmental exposures, and neuroendocrine stress signaling—not just diet—plans that target only one lever frequently underperform. The most consistent improvements typically come from individualized, barrier-supportive skin care paired with microbiome strategies that restore diversity and metabolite production over time, rather than generic, short-term “gut detox” or broad elimination alone.

  • Common mistakes

    • Treating adult atopic dermatitis with a one-size-fits-all diet (e.g., broad eliminations) despite the condition being driven by individual gut–skin immune and microbiome context rather than a single trigger or organism.
    • Skipping fermentable fiber strategy and using random supplementation (or only probiotics) instead of restoring a diverse fiber-fermenting ecosystem that supports anti-inflammatory SCFAs (e.g., butyrate/propionate).
    • Assuming symptom relief equals microbiome repair and stopping too early; failing to account for the weeks-to-months lag needed for microbial resilience, SCFA metabolite output, and gut barrier recovery after antibiotics/illness/diet shifts.
    • Over-restricting foods or dramatically changing diet quickly, which can reduce microbial diversity and worsen metabolite production—making flares more likely rather than less.
    • Ignoring medication history and gut-disrupting events (especially antibiotics), and not planning for post-disruption stabilization to rebuild ecosystem function.
    • Targeting only diet while neglecting skin barrier care and the itch–scratch amplification loop; gut interventions alone often underperform if barrier dysfunction remains active.
    • Not accounting for individual fiber tolerance and GI variability (e.g., certain fermentable fibers may worsen symptoms or adherence), leading to poor compliance or new inflammation triggers.
    • Overlooking other drivers that interact with gut inflammation (stress load, infections, environmental irritants), and focusing narrowly on “gut detox” rather than coordinated immune and barrier support.

What to do

  • General support strategies

    Adult atopic dermatitis is driven by immune dysregulation and an impaired skin barrier, and the gut–skin axis appears to influence how easily flares start and how intense they become. When the gut microbiome is diverse, it can generate metabolites—such as short-chain fatty acids—that help regulate inflammatory signaling and support immune tolerance. In contrast, gut dysbiosis can favor a more pro-inflammatory immune environment, meaning that skin inflammation may escalate more readily in response to stress, infections, or environmental triggers.

    A practical support strategy is to prioritize dietary patterns that promote microbial diversity and gut barrier integrity. Increasing dietary fiber (from vegetables, legumes, whole grains, and seeds) can nourish beneficial microbes, while reducing ultra-processed foods may help limit gut-disrupting effects that can accompany dysbiosis. Consistent nutrition habits matter as well, because large dietary swings or insufficient overall intake can stress microbial stability. In addition, be cautious with non-essential antibiotic exposure, since it can temporarily reduce microbiome resilience; when antibiotics are medically necessary, discussing probiotic timing and duration with a clinician may be helpful.

    Because AD has no single “magic” food or germ cause, support is usually most effective when paired with core skin barrier care and personalized trigger awareness. For some people, individualized adjustments—such as identifying dietary patterns that correlate with flares or improving intake of microbiome-supporting fibers—may help lower the inflammatory “baseline” that fuels itching and the itch–scratch cycle. Overall, the goal is to help the immune system stay better regulated by supporting gut microbial balance alongside evidence-based dermatologic management.

  • Lifestyle recommendations

    • Prioritize a high-fiber, minimally processed diet (e.g., fruits, vegetables, legumes, whole grains) to support gut microbiome diversity.
    • Reduce intake of ultra-processed foods and added sugars, which can worsen gut dysbiosis and inflammatory signaling.
    • Use antibiotics only when truly needed and discuss timing/need with a clinician; avoid unnecessary courses that can disrupt microbiome balance.
    • Support regular, consistent eating patterns and overall nutrition (avoid frequent skipping of meals and extreme dieting) to help maintain gut barrier function and immune tolerance.
    • Identify and limit personal diet/environment triggers for flares (through symptom tracking), rather than eliminating foods broadly without evidence.
    • Pair microbiome-supportive habits with core AD skin barrier care (consistent moisturization and prescribed anti-inflammatory treatments) to reduce itch-scratch cycling and inflammation.

  • Nutrition recommendations

    • Increase dietary fiber (25–38 g/day) from diverse plant sources—e.g., beans/lentils, oats, quinoa, vegetables, berries—to support gut microbial diversity and production of anti-inflammatory short-chain fatty acids (SCFAs).
    • Prioritize minimally processed, whole-food patterns (Mediterranean-style when possible) and limit ultra-processed foods and added sugars, which are associated with gut dysbiosis and heightened inflammation.
    • Consume fermented foods regularly if tolerated (e.g., yogurt with live cultures, kefir, sauerkraut, kimchi) to introduce beneficial microbes and metabolites that may help regulate immune signaling.
    • Include prebiotic foods that selectively feed “good” microbes (e.g., garlic, onions, leeks, asparagus, bananas/plantains once cooled for resistant starch, oats) to strengthen gut barrier function.
    • Choose adequate omega-3 fats (fatty fish 2x/week or consider algae-based EPA/DHA) and ensure sufficient total calories/protein to support skin barrier repair and modulate inflammatory pathways.
    • Use an individualized approach to potential food triggers—avoid only foods that consistently worsen symptoms (not broad elimination)—and consider guidance from an allergist/dietitian if recurrent flares suggest specific sensitivities.
    • Be cautious with unnecessary antibiotic exposure; when antibiotics are clinically needed, support recovery with fiber-rich foods and fermented/prebiotic intake (and discuss probiotics with your clinician).

  • Supplement considerations

    For adult atopic dermatitis, supplement strategies typically focus on supporting immune regulation and gut barrier function, because gut dysbiosis can amplify systemic inflammatory tone that “echoes” into the skin. When the microbiome is diverse, microbial metabolites such as short-chain fatty acids (e.g., butyrate) help maintain immune tolerance and can dampen pro-inflammatory signaling. Supplements that promote microbial balance or bolster tolerance-oriented pathways may therefore complement standard skin barrier care (emollients, prescribed therapies) by potentially reducing flare frequency, itch intensity, and the tendency for inflammation to escalate.

    In practice, probiotic and prebiotic approaches are often considered, but responses can vary by strain and baseline microbiome. Prebiotics (like fermentable fibers) may help increase beneficial metabolite production and improve microbial resilience, while selected probiotic blends may influence immune pathways involved in atopic inflammation. Omega-3 fatty acids are another common consideration because they can support anti-inflammatory signaling, which may be helpful during active flare states. Because antibiotics, low-fiber diets, and high intakes of ultra-processed foods can shift microbial composition, supplement use is often most effective when paired with dietary changes that favor microbial diversity.

    Supplement decisions should also account for safety, timing, and individual triggers. For example, during very active or weeping skin flares, it’s prudent to avoid unnecessary additions and prioritize well-tolerated options; anyone who is immunocompromised should discuss probiotics with a clinician. It’s also important to recognize that no single supplement fixes AD, so the best approach is usually a personalized trial with monitoring of skin and GI symptoms over several weeks, alongside consistent barrier-focused skin treatment, stress and infection trigger awareness, and adherence to any prescribed AD regimen.

  • Retesting / monitoring note

    For adult atopic dermatitis, retesting should be considered when there is a meaningful change in symptoms, treatment regimen, or potential gut microbiome disruptors (for example, antibiotics, travel-related diet changes, major shifts in fiber intake, or new high–ultra-processed food patterns). Because the gut–skin axis involves immune signaling and metabolite production (such as short-chain fatty acids), microbiome-related influences can evolve over weeks rather than days. Retesting is most informative when timed to capture a new steady state after an intervention or a trigger event, rather than during the immediate flare window.

    In practice, retesting is often most useful for monitoring patterns linked to gut dysbiosis risk—such as persistently low fiber intake, ongoing gastrointestinal symptoms, or recurrent flare susceptibility—especially if earlier results or observations did not translate into clinical improvement. If a patient adopts a microbiome-supportive dietary strategy (e.g., increasing diverse fiber sources) and maintains consistent core skin barrier therapy, reassessment is typically warranted after a sufficient period to allow microbial communities and their metabolite output to stabilize. This helps determine whether immune tone may be shifting in a less pro-inflammatory direction, which can correlate with reduced itch severity and fewer or milder flares.

    Retesting should also be revisited when symptoms change in a way that suggests an updated driver (for example, new medication exposures, infections, or altered stress levels that can interact with gut immunity). Since there is rarely a single “culprit” bacterium or food, re-evaluation is best framed as tracking immune–metabolite balance and gut barrier resilience over time, alongside standard AD management. Clear retesting goals—such as confirming whether a prior nutrition/microbiome plan is working or identifying whether another disruption has reintroduced dysbiosis—can improve interpretability and guide personalized next steps.

The importance of gut microbiome testing

  • Why testing matters

    For adult atopic dermatitis, gut microbiome testing can matter because the gut–skin axis appears to influence how easily inflammatory signals build and persist. While AD is rooted in immune dysregulation and a weakened skin barrier, gut dysbiosis may shift immune tone through altered microbial metabolites (such as short-chain fatty acids) and increased gut permeability. Those changes can make the skin more “flare-prone,” helping explain why some people experience more frequent itching, redness, and thickened patches during periods of stress, infection, or dietary inconsistency.

    Testing is also useful because it moves gut-focused recommendations from generic to more individualized. Two adults can eat similarly but have different baseline microbiome diversity, functional capacity, and stability—so the same approach (for example, adding fiber or adjusting probiotics) may work better for some than others. Identifying patterns like reduced diversity, an unfavorable balance of fermentation pathways, or post-antibiotic disruption can help clinicians and patients tailor diet and lifestyle changes that support beneficial microbes and strengthen immune tolerance rather than relying on trial-and-error.

    Finally, gut microbiome results can help track whether interventions are actually shifting the ecosystem that supports inflammation control. For AD, that could mean observing whether dietary changes increase microbial metabolites linked to immune regulation and barrier support, potentially helping reduce itch-scratch cycling and flare intensity when combined with standard skin barrier therapy. In other words, microbiome testing can provide actionable context for timing, personalization, and monitoring—complementing core AD care to better manage long-term symptom patterns.

  • How InnerBuddies helps

    For adults with atopic dermatitis, the InnerBuddies test can help clarify whether gut dysbiosis is potentially contributing to a more flare-prone immune environment via the gut–skin axis. By looking at the state and functional tendencies of the gut microbiome, it can provide insight into patterns associated with reduced microbial diversity, shifts in immune-modulating fermentation activity, and signs that may align with increased inflammatory signaling. This matters because intestinal barrier strain and altered microbial metabolites (including short-chain fatty acids) can influence immune tolerance and inflammatory tone that “echo” back to the skin.

    InnerBuddies can also make gut-focused support more individualized. Instead of relying on generic advice like “add more fiber” or “try probiotics,” the results can guide more targeted, practical diet and lifestyle adjustments based on your current ecosystem—for example, emphasizing specific fiber-rich patterns that support beneficial metabolite production, or addressing likely disruptions after antibiotics or other changes that can destabilize the microbiome. That personalization can help reduce the guesswork behind diet and microbiome interventions, especially for people whose AD symptoms appear to worsen with stress, infections, or inconsistent nutrition.

    Finally, the test can support monitoring over time—helping you see whether your chosen interventions are actually shifting the gut ecology in the direction associated with improved immune regulation. In the context of atopic dermatitis, that can mean tracking whether dietary or microbiome-support changes correspond with calmer inflammatory signaling and reduced flare intensity when paired with core skin barrier care. By using results to time, tailor, and reassess interventions, InnerBuddies can complement standard AD management and help you work toward more consistent symptom control.

Medical Evidence

  • Scientific evidence level

    2 [weak / emerging but inconsistent]

  • Clinical relevance note

    Current clinical relevance is low. While mechanistic studies and some human observational findings support a possible “gut–skin” immunologic link, the evidence is not yet strong enough to use the gut microbiome in routine care for adult atopic dermatitis. Associations are inconsistent across studies, effect sizes are not reliably established, and key methodological confounders are difficult to eliminate. Longitudinal, predictive, and externally validated biomarker evidence is missing.

    Similarly, microbiome-targeted interventions have not demonstrated consistently reproducible improvements in clinically meaningful AD outcomes. Because microbiome composition varies with diet, geography, sampling, and medications, and because many trials differ in strains/doses and endpoints, it is premature to treat gut microbiome modulation as a reliable therapeutic strategy specifically for adult AD. At present, microbiome testing is not a validated tool for prevention, diagnosis, or treatment selection/monitoring in adult atopic dermatitis; any use would be research-level rather than evidence-based clinical practice.

Title Journal Year Link
Gut microbiome and atopic dermatitis: a systematic review and meta-analysis Frontiers in Cellular and Infection Microbiology 2020 View →
Alterations of the gut microbiota in adult patients with atopic dermatitis Journal of Dermatology 2019 View →
Probiotics for the prevention and treatment of atopic dermatitis: a meta-analysis of randomized controlled trials Journal of Allergy and Clinical Immunology 2018 View →
Gut microbiota composition is associated with atopic dermatitis in children: a systematic review Journal of Dermatological Science 2017 View →
Gut Microbiota in Atopic Dermatitis Is Associated With Disease Severity and IgE Levels Cell Host & Microbe 2016 View →

Frequently Asked Questions

    Qu'est-ce que la dermatite atopique chez l'adulte ?
    Une maladie inflammatoire chronique de la peau caractérisée par des démangeaisons, une peau sèche et une barrière cutanée altérée; les poussées peuvent être déclenchées par le stress, les infections et l'environnement.
    Comment l’axe intestin–peau influence-t-il les poussées ?
    Le microbiote intestinal peut moduler les signaux immunitaires ; la dysbiose peut favoriser l’inflammation et affecter la peau, sans être la seule cause.
    Les aliments peuvent-ils causer ou déclencher l’eczéma ?
    Il n’existe pas d’aliment unique qui provoque l’AD. Certaines personnes identifient des déclencheurs individuels ; cela varie selon chacun.
    Quels sont les symptômes courants chez l’adulte ?
    Démangeaisons, peau sèche et rugueuse, plaques rouges, épaississement cutané et, dans les cas sévères, croûtes.
    Quels changements alimentaires pourraient aider ?
    Privilégier les aliments riches en fibres, limiter les aliments ultra-transformés et maintenir des repas réguliers. Discuter des déclencheurs personnels avec un professionnel.
    Quel est le rôle des acides gras à chaîne courte (SCFA) ?
    Les SCFA aident à réguler les signaux immunitaires et la tolérance. Des niveaux plus bas peuvent être liés à une inflammation accrue.
    Le test du microbiome intestinal est-il utile ?
    Oui, il peut aider à personnaliser les conseils diététiques et le mode de vie; il ne remplace pas un traitement médical et les résultats doivent être discutés avec un médecin.
    Qu’est-ce que le test InnerBuddies ?
    Une évaluation du microbiome intestinal qui examine la diversité et les capacités fonctionnelles pour guider les choix diététiques et le mode de vie en complément des soins cutanés.
    Comment soutenir la barrière cutanée tout en améliorant la santé intestinale ?
    Utiliser des soins de barrière adaptés et adopter une alimentation riche en fibres et d’autres habitudes bénéfiques pour le microbiome.
    Les antibiotiques ou les infections aggravent-ils la maladie ?
    Les antibiotiques peuvent perturber le microbiome; le stress et les infections peuvent déclencher des poussées. Consulter un professionnel si nécessaire.
    Comment savoir si les changements aident ?
    Surveiller le prurit, la rougeur et la sécheresse au fil du temps et discuter des résultats avec votre médecin.
    Devrais-je parler des tests du microbiome avec mon médecin ?
    Oui, discutez du but, des résultats et de leur intégration dans votre prise en charge de l’AD.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -